As expected, the immunofluorescent area occupied by SOD1 in the spinal cord was higher in end stage ALS mice than in symptomatic mice (defined by 10% weight loss) (Fig. 4f–h). Here, SOD1 is linked to amyotrophic lateral sclerosis.